Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Molecular Cancer Therapeutics|October 2, 2025
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumorsKyle B Williams, Alex T Larsson, Bryant J Keller, et al.
Nature Communications|November 7, 2020
Scalable continuous evolution for the generation of diverse enzyme variants encompassing promiscuous activitiesGordon Rix, Ella J Watkins-Dulaney, Patrick J Almhjell, et al.
Microbial Biotechnology|March 1, 2021
Integrating continuous hypermutation with high-throughput screening for optimization of cis,cis-muconic acid production in yeastEmil D Jensen, Francesca Ambri, Marie B Bendtsen, et al.
Journal of the American Chemical Society|June 27, 2009
Evolution of proteins with genetically encoded "chemical warheads"Chang C Liu, Antha V Mack, Eric M Brustad, et al.
Nature Methods|October 2, 2012
An adaptor from translational to transcriptional control enables predictable assembly of complex regulationChang C Liu, Lei Qi, Julius B Lucks, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
A massively parallel <i>in vivo</i> assay of TdT mutants yields variants with altered nucleotide insertion biasesCourtney K Carlson, Theresa B Loveless, Marija Milisavljevic, et al.
ACS Synthetic Biology|September 20, 2024
A Massively Parallel <i>In Vivo</i> Assay of TdT Mutants Yields Variants with Altered Nucleotide Insertion BiasesCourtney K Carlson, Theresa B Loveless, Marija Milisavljevic, et al.
ACS Chemical Biology|December 15, 2025
Continuous Hypermutation and Evolution of Luciferase VariantsTanya Hadjian, Ria A Deshpande, Zachary R Torrey, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Continuous hypermutation and evolution of luciferase variantsTanya Hadjian, Ria A Deshpande, Zachary R Torrey, et al.
Pageof 7